Aurobindo Pharma reported results for the fourth quarter ended March 31, 2013.
The company has reported a rise of 87.09% in its net profit at Rs 163.54 crore in Q4FY13 as compared to net profit of Rs 87.91 crore in the same quarter previous year. Total income of the company has increased by 34.45% to Rs 1479.56 crore as compared to Rs 1100.41 crore in corresponding quarter last year.
For the full year ended March 31, 2013, the company has posted net profit of Rs 495.99 crore as compared to the net loss of Rs 42.61 crore for the same period in the previous year. The total income from operations has increased by 26.50% at Rs 5440.11 crore for year under review as compared to Rs 4300.51 crore for the period ended March 31, 2012.
On consolidated basis, for the full year ended March 31, 2013, the company has posted net profit after taxes & Minority Interest of Rs 293.85 crore as compared to the net loss of Rs 123.50 crore for the same period in the previous year. The total income from operations has increased by 26.48% at Rs 5883.85 crore for year under review as compared to Rs 4652.10 crore for the period ended March 31, 2012.
